1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. OPUS GENETICS INC.
Opus Genetics Inc. XNAS: IRD

Opus Genetics Inc. Live Stock Price Today, Share Analysis and Chart

about

Opus Genetics Inc is a clinical-stage ophthalmic biopharmaceutical company developing therapies to treat patients with inherited retinal diseases (IRDs) and therapies to treat patients with other retinal and refractive disorders. The pipeline include...

Read More
1.22 0.03 (2.52%)
30.29% Fall from 52W High
160.0K
XNAS Volume

XNAS 29 Aug, 2025 4:02 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Not Eligible
-
Valuation Score
Expensive Valuation
11.2 / 100
Momentum Score
Technically Moderately Bullish
62.8 / 100
Analyst Price Target
6
1Yr Price target upside is 392%
4 analysts

15

S

7

W

0

O

3

T

SWOT Analysis

Opus Genetics Inc. Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..